NPPES file of Aug 9, 2026

Sandrine Niyongere, M.D.

Hematology & Oncology Physician · Baltimore, MD

Sandrine Niyongere, M.D. is a hematology & oncology physician with a practice address in Baltimore, Maryland, and NPI 1386908119, issued on Jun 26, 2012. Check the license (Maryland D0085404, as entered in NPPES) on the Maryland Board of Physicians; the Medicare figures below come from public CMS files.

Record from CMS NPPES, file of Aug 9, 2026 · Medicare files 2023 and 2024 · method · Verify with CMS →

NPPES recordNPPES file of Aug 9, 2026
1386908119
Name
Sandrine Niyongere
Credential
M.D.
Primary taxonomy
Hematology & Oncology Physician 207RH0003X
License numbers
D0085404 MD
125061646 IL
Self-reported in NPPES; status is on the state search
Practice location
22 S Greene St, Baltimore, MD 21201
Phone
(410) 328-8708
Enumerated
Jun 26, 2012
Record last updated
May 11, 2018 (not updated in 8 years: call before relying on the address or phone)
Fax
(410) 328-6896
Medicare enrollment
Enrolled (PECOS I20180618000068); accepts Medicare assignment
Telehealth
Offers telehealth (CMS)
Entity
Type 1 · individual
Public record from CMS NPPES (open it on the CMS NPI Registry). Enrollment, assignment, school and telehealth: CMS Doctors and Clinicians file, Aug 2026. A record is not a license: verify it with the state board.
Download card Updates feed

Also registered at 22 S Greene St

A shared address usually means a shared clinic or building; it does not show who employs whom.

  1. Bizhan Aarabi, MDNeurological Surgery Physician1174578876
  2. Elsadig Abdalla, MDStudent in an Organized Health Care Education/Training Program1073364477
  3. Ehssan AbdolalizadehStudent in an Organized Health Care Education/Training Program1093653271
  4. Mohammad Abdulelah, MDStudent in an Organized Health Care Education/Training Program1114650108
  5. Leenah AbdulgaderStudent in an Organized Health Care Education/Training Program1386323301
  6. Ifedayo Abiola-Matthew, CRNPAcute Care Nurse Practitioner1033781117

Verify Sandrine Niyongere in five checks

  1. 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
  2. 2LicenseActive license and public ordersMaryland Board of Physicians
    Search for license D0085404
    Check the board
  3. 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
  4. 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
  5. 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
Open the Maryland license search

PlainDoctor does not match the HHS-OIG exclusion list to individual records: most entries carry no NPI. Search the OIG exclusion list by name.

Is this page about you? You can ask us to correct, restrict or remove it: how.

36% fewer Medicare Part D claims than the average hematology & oncology physician in 2024

557 Medicare Part D claims for 52 beneficiaries, against an average of 877 among the 10,784 providers of this specialty who prescribed in Part D. 27 claims were for opioids.

  1. Sandrine Niyongere557
  2. Specialty average877

Most prescribed

  1. Imatinib Mesylate46 claims
  2. Acyclovir45 claims
  3. Hydroxyurea43 claims
  4. Allopurinol26 claims
  5. Eliquis25 claims
  6. Ondansetron Hcl25 claims

Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.

The practice group's MIPS final score for 2023 (Medicare payment program): 100 of 100

The Merit-based Incentive Payment System score is reported for the practice group, not for one clinician alone. Four categories are weighted into the final score; the average among 454,083 clinicians with a measured score was 83.5.

  1. Qualitynot scored (reweighted)
  2. Costnot scored (reweighted)
  3. Promoting interoperabilityout of 100 · 25%99.0
  4. Improvement activities40 of 40 points · 15%100.0

Source: CMS Quality Payment Program, MIPS performance year 2023, group reporting; category weights for 2023 (qpp.cms.gov).

Industry payments in 2024: $32.51

1 payment: food and beverage; the largest payer was AstraZeneca Pharmaceuticals LP. The 8,560 providers of this specialty with any payment received $7,481.41 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.

  1. Sandrine Niyongere$32.51
  2. Specialty average$7,481.41

Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.

Bills Medicare through one group practice

  1. University OF Maryland Oncology Associates PABaltimore, MD

Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).

Sandrine Niyongere among 317 hematology & oncology physician records in Maryland

Sandrine Niyongere, M.D. is one of 317 hematology & oncology physician records with a practice address in Maryland. 75% of them appear in a Medicare file (Part D prescribing, MIPS, Open Payments or Medicare group billing); this one does. Its NPI, issued in 2012, is newer than 74% of them.

  • NPI issued2012 · 74% of these records are older, 23% newer
  • In a Medicare fileYes · 75% of these records are
  • In the CMS Doctors and Clinicians fileYes · 58% of these records are
  • Graduated2012 · median 2000 among the 185 with a school on file
  • Record last updated2018 · 57% of these records were not updated in five years or more

Source: CMS NPPES, file of Aug 9, 2026, every record with primary taxonomy 207RH0003X and a Maryland practice address; Medicare files: CMS Part D Prescribers 2024, MIPS 2023, Open Payments 2024, Doctors and Clinicians (data.cms.gov).

Hematology & Oncology Physician providers in Maryland

There are 317 hematology & oncology physician records in Maryland.

The 8 hematology & oncology physician records with the nearest ZIP codes

  1. Maria Baer, MDBaltimore, MD 212011700881802
  2. Arnob Banerjee, MDBaltimore, MD 212011538221494
  3. Trishna Goswami, M.D.Baltimore, MD 212011336201474
  4. Jack Hong, M.D.Baltimore, MD 212011033186085
  5. Yixing Jiang, MDBaltimore, MD 212011720037971
  6. Mehmet Kocoglu, MDBaltimore, MD 212011114001138
  7. Naimish Pandya, MDBaltimore, MD 212011497709356
  8. Douglas Ross, MDBaltimore, MD 212011861447666

Common questions

What is Sandrine Niyongere, M.D.'s NPI number?

Sandrine Niyongere, M.D.'s National Provider Identifier (NPI) is 1386908119, issued on Jun 26, 2012. An NPI identifies a provider in billing; it is not a license.

Where is Sandrine Niyongere, M.D. located?

The NPPES record lists a practice address at 22 S Greene St, Baltimore, MD, 21201. Phone: (410) 328-8708. Providers update this record themselves, so call before visiting.

How can I verify Sandrine Niyongere, M.D.'s license?

NPPES lists Maryland license number D0085404, as entered by the provider. Search the Maryland Board of Physicians at https://www.mbp.state.md.us/. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.

How much does Sandrine Niyongere, M.D. prescribe under Medicare Part D?

In 2024, Sandrine Niyongere, M.D. had 557 Medicare Part D claims for 52 beneficiaries; the average among hematology & oncology physician prescribers was 877. Part D covers Medicare prescriptions only.

What is Sandrine Niyongere, M.D.'s MIPS final score?

The 2023 MIPS final score is 100 of 100, reported for the practice group. The average among 454,083 clinicians with a measured score was 83.5.

Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.

Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.